CND Life Sciences Closes Series Seed 3 Round, Reaches $12.5 Million In Total Equity Raised
CND has raised an additional $1 million in venture funding from Top Corner Capital Scottsdale, Arizona. , April 6, 2023 /PRNewswire/ — CND Life Sciences, a leading medical technology company developing reliable skin tests to help doctors diagnose neurodegenerative diseases such as Parkinson's disease and Lewy body dementia, today announced an initial third round of … Read more